Ionis Pharma (IONS): Balans kapitallashuviga qarzlar

Ionis Pharma (IONS) kompaniyasining korporativ logotipi

Ionis Pharmaceuticals (IONS) klinik sinov xarajatlari va hamkorlarga bog'liqlik muammolariga duch kelmoqda. Xatarlar gen terapiyalarining uzoq davom etadigan ishlab chiqish sikli va potentsial sinovlar muvaffaqiyatsizligi bilan bog'liq. Shu bilan birga, kompaniya RNA terapevtikasi sohasida hurmatga sazovor innovator sifatidagi maqomini saqlab qolmoqda. 5.36 qiymati ushbu grafikda qarzning kompaniya kitob kapitalizatsiyasiga nisbatdagi joriy koeffitsientini aks ettiradi.

Ionis Pharmaceuticals (IONS) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

Ionis Pharmaceuticals, Inc. (IONS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Ionis Pharmaceuticals|IONS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Isis Pharmaceuticals|IONS - Kompaniyani sotib olish narxi
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Ionis|IONS - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati ionispharma.com|IONS - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Ionis Pharmaceuticals|IONS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Ionis Pharma|IONS - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans qiymatiga nisbati Isis Pharmaceuticals
Kompaniyaning barcha koʻrsatkichlari tahlili:IONS, Ionis Pharmaceuticals
Ionis Pharma brendining mahsuloti

Notsiklik biotexnologiya kompaniyasi Ionis Pharmaceuticals (IONS) uchun umumiy qarzdorlikning kitob kapitalizatsiyasiga nisbati qimmatbaho klinik sinovlar o'tkazishda moliyaviy avtonomiyaning ko'rsatkichi bo'lib xizmat qiladi. Umumiy majburiyatlarning kapitalga nisbati leveraj darajasini belgilaydi: koeffitsiyentning pasayishi kompaniyaning to'lov qobiliyatini mustahkamlaydi, biroq qarz olishda haddan tashqari konservativlik RNA terapiyasi bozoridagi kengayish sur'atlarini sekinlashtirishi mumkin.

Ionis Pharmaceuticals kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|Balans kapitallashuviga qarzlar qiagen.com QGEN|Balans kapitallashuviga qarzlar RGEN (Repligen)|RNA: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati CRSP|WGS (GeneDx Corp) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Ultragenyx Pharmaceutical (RARE)|Qarzning balans qiymatiga nisbati beamtx.com|SRPT (Sarepta) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar TWST (Twist Bioscience Inc)|Qarzning balans kapitallashuviga nisbati TXG|NTLA - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Stoke Therapeutics (STOK)|BLFS: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Wave Life Sciences Ltd. (WVE)|Maze Therapeutics, Inc. (MAZE) - Qarzlarning balans kapitallashuviga nisbati|SION - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Prime Medicine Bio|Balans kapitallashuviga qarzlar TSHA|Balans kapitallashuviga qarzlar QURE (uniqure.com)|Qarzning balans kapitallashuviga nisbati MeiraGTx|REGENXBIO Inc - Qarzning sof aktivlarga nisbati|SLDB: Qarzning balans kapitallashuviga nisbati|OCGN - Qarzning balans qiymatiga nisbati|PACB: Balans kapitallashuviga qarzlar|benitec.com (BNTC) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar DSGN|Qarzning balans qiymatiga nisbati Rocket Pharma|4D Molecular Therapeutics Inc - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar lexeotx.com LXEO|Qarzning balans qiymatiga nisbati KRRO (Korro Bio)|EDIT - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Silence Therapeutics plc SLN|PRQR - Qarzning balans kapitaliga nisbati|codexis.com - Balans kapitallashuviga qarzlar|Sangamo BioSciences (SGMO) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar NAUT|Qarzning balans qiymatiga nisbati metagenomi.co|Balans kapitallashuviga qarzlar DTIL|Balans kapitallashuviga qarzlar GBIO (generationbio.com)|Qarzning balans kapitallashuviga nisbati Boundless Bio, Inc BOLD|Exicure Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati IMNN (Celsion Corporation)|PHIO - Sof aktivlarga qarzlar|mustangbio.com - Balans kapitallashuviga qarzlar|RNAZ (TransCode Therapeutics, Inc.) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati BNGO (Bionano Genomics Inc.)|Balans qiymatiga qarzlar APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. BLUE|Qarzning balans qiymatiga nisbati IPA (immunoprecise.com)|Qarzning balans kapitallashuviga nisbati OMGA|Sof aktivlarga qarzlar Singular Genomics Systems, Inc. OMIC|Regulus Therapeutics Inc (RGLS) - Balans kapitallashuviga qarzlar|SYRS: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Telesis Bio, Inc.|traconpharma.com (TCON) - Qarzning balans qiymatiga nisbati|UBX (Unity Biotechnology, Inc.) - Balans kapitallashuviga qarzlar